Effects of Clozapine for Non-Treatment-Resistant Patients with Schizophrenia
Date
1999
Authors
Galletly, C.
Clark, C.
McFarlane, A.
Weber, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Psychiatric Services, 1999; 50(1):101-103
Statement of Responsibility
Conference Name
Abstract
Clozapine is generally used for patients meeting criteria for treatment resistance. In this study clozapine was given to 19 patients with schizophrenia who did not meet these criteria and whose symptoms were mild to moderate in severity. Clozapine was associated with significant improvement in positive and negative symptoms and quality of life. A more modest improvement on a range of tests of cognitive functioning was also noted. These results suggest that consideration should be given to broadening the usual criteria for patients' eligibility for clozapine treatment.